Intel has developed new software known as Collaborative Cancer Cloud. It will help cancer researchers to share sequenced genomes, medical images and clinical information. The company wants to offer a software platform for a system that will most probably run on Intel-based hardware to collect data from different sources. It will allow researchers from different institutions to collaborate.

Intel is not the first one to start such an initiative, which as per experts is a coming age of personalized medicine. Apple, Collaborative Cancer Cloud and many other businesses are competing to provide computing infrastructure to actualize the vision of an era in which doctors will use data from genomics, wearable devices and medical records to develop treatment for their patients.

Intel said that USP of its system is security and privacy. Intel has developed the software with Oregon Health and Science University, under an open source license, which means it would cost nothing for sharing and modifying.

It is expected that the software will be launched in early 2016. Eric Dishman, Intel’s General Manager for Health and Life Sciences said that there is a personal connection with the software. He is a cancer survivor and genomics has saved his life.

It can take up to 21 days to genome sequencing and that much time must not be with every cancer patient. Data centers having the ability to process this information will get the job done faster.